- Home
- SLNO vs PLUS Comparison
SLNO vs PLUS Comparison
Compare SLNO & PLUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNO
- PLUS
- Stock Information
- Founded
- SLNO 1999
- PLUS 1990
- Country
- SLNO United States
- PLUS United States
- Employees
- SLNO N/A
- PLUS N/A
- Industry
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- PLUS Retail: Computer Software & Peripheral Equipment
- Sector
- SLNO Health Care
- PLUS Technology
- Exchange
- SLNO Nasdaq
- PLUS Nasdaq
- Market Cap
- SLNO 1.9B
- PLUS 2.1B
- IPO Year
- SLNO 2014
- PLUS 1996
- Fundamental
- Price
- SLNO $45.18
- PLUS $74.00
- Analyst Decision
- SLNO Strong Buy
- PLUS Hold
- Analyst Count
- SLNO 6
- PLUS 1
- Target Price
- SLNO $74.83
- PLUS $90.00
- AVG Volume (30 Days)
- SLNO 788.7K
- PLUS 200.2K
- Earning Date
- SLNO 11-06-2024
- PLUS 02-04-2025
- Dividend Yield
- SLNO N/A
- PLUS N/A
- EPS Growth
- SLNO N/A
- PLUS N/A
- EPS
- SLNO N/A
- PLUS 4.03
- Revenue
- SLNO N/A
- PLUS $2,123,226,000.00
- Revenue This Year
- SLNO N/A
- PLUS $1.96
- Revenue Next Year
- SLNO N/A
- PLUS $7.36
- P/E Ratio
- SLNO N/A
- PLUS $18.36
- Revenue Growth
- SLNO N/A
- PLUS N/A
- 52 Week Low
- SLNO $35.70
- PLUS $56.33
- 52 Week High
- SLNO $60.92
- PLUS $106.98
- Technical
- Relative Strength Index (RSI)
- SLNO 32.12
- PLUS 30.83
- Support Level
- SLNO $43.32
- PLUS $73.67
- Resistance Level
- SLNO $48.51
- PLUS $78.72
- Average True Range (ATR)
- SLNO 2.09
- PLUS 2.55
- MACD
- SLNO -0.38
- PLUS -0.18
- Stochastic Oscillator
- SLNO 20.44
- PLUS 11.53
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.
About PLUS ePlus inc.
ePlus Inc is a holding company. ePlus through its subsidiaries provides information technology solutions. The company's technology solutions enable organizations to optimize their IT environment and supply chain processes. It also provides consulting, professional and managed services, and complete lifecycle management services including flexible financing solutions. ePlus focuses on selling to medium and large enterprises in the United States and to customers in select international markets including the United Kingdom, the European Union, India, Singapore and Israel.